CAST: A retrospective analysis of cabazitaxel and abiraterone acetate sequential treatment in patients with metastatic castrate-resistant prostate cancer previously treated with docetaxel

M.D. Wissing; J.L.L.M. Coenen; P. van den Berg; H.M. Westgeest; A.J.M. van den Eertwegh; I.M. van Oort; M.M. Bos; A.M. Bergman; P. Hamberg; A.J. ten Tije; M. Los; M.P.J.K. Lolkema; R. de Wit; H. Gelderblom

doi:10.1002/ijc.29231

CAST: A retrospective analysis of cabazitaxel and abiraterone acetate sequential treatment in patients with metastatic castrate-resistant prostate cancer previously treated with docetaxel

M.D. Wissing, J.L.L.M. Coenen, P. van den Berg, H.M. Westgeest, A.J.M. van den Eertwegh, I.M. van Oort, M.M. Bos, A.M. Bergman, P. Hamberg, A.J. ten Tije, M. Los, M.P.J.K. Lolkema, R. de Wit, H. Gelderblom

Medical oncology

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	E760-E772
Journal	International Journal of Cancer
Volume	136
Issue number	6
DOIs	https://doi.org/10.1002/ijc.29231
Publication status	Published - 2015

Access to Document

10.1002/ijc.29231

Cite this

Wissing, M. D., Coenen, J. L. L. M., van den Berg, P., Westgeest, H. M., van den Eertwegh, A. J. M., van Oort, I. M., Bos, M. M., Bergman, A. M., Hamberg, P., ten Tije, A. J., Los, M., Lolkema, M. P. J. K., de Wit, R., & Gelderblom, H. (2015). CAST: A retrospective analysis of cabazitaxel and abiraterone acetate sequential treatment in patients with metastatic castrate-resistant prostate cancer previously treated with docetaxel. International Journal of Cancer, 136(6), E760-E772. https://doi.org/10.1002/ijc.29231

Wissing, M.D. ; Coenen, J.L.L.M. ; van den Berg, P. ; Westgeest, H.M. ; van den Eertwegh, A.J.M. ; van Oort, I.M. ; Bos, M.M. ; Bergman, A.M. ; Hamberg, P. ; ten Tije, A.J. ; Los, M. ; Lolkema, M.P.J.K. ; de Wit, R. ; Gelderblom, H. / CAST: A retrospective analysis of cabazitaxel and abiraterone acetate sequential treatment in patients with metastatic castrate-resistant prostate cancer previously treated with docetaxel. In: International Journal of Cancer. 2015 ; Vol. 136, No. 6. pp. E760-E772.

@article{3e49ffebd1994aef96951cc87f2ec186,

title = "CAST: A retrospective analysis of cabazitaxel and abiraterone acetate sequential treatment in patients with metastatic castrate-resistant prostate cancer previously treated with docetaxel",

author = "M.D. Wissing and J.L.L.M. Coenen and {van den Berg}, P. and H.M. Westgeest and {van den Eertwegh}, A.J.M. and {van Oort}, I.M. and M.M. Bos and A.M. Bergman and P. Hamberg and {ten Tije}, A.J. and M. Los and M.P.J.K. Lolkema and {de Wit}, R. and H. Gelderblom",

year = "2015",

doi = "10.1002/ijc.29231",

language = "Undefined/Unknown",

volume = "136",

pages = "E760--E772",

journal = "International Journal of Cancer",

issn = "0020-7136",

publisher = "Wiley-Liss Inc.",

number = "6",

}

Wissing, MD, Coenen, JLLM, van den Berg, P, Westgeest, HM, van den Eertwegh, AJM, van Oort, IM, Bos, MM, Bergman, AM, Hamberg, P, ten Tije, AJ, Los, M, Lolkema, MPJK, de Wit, R & Gelderblom, H 2015, 'CAST: A retrospective analysis of cabazitaxel and abiraterone acetate sequential treatment in patients with metastatic castrate-resistant prostate cancer previously treated with docetaxel', International Journal of Cancer, vol. 136, no. 6, pp. E760-E772. https://doi.org/10.1002/ijc.29231

CAST: A retrospective analysis of cabazitaxel and abiraterone acetate sequential treatment in patients with metastatic castrate-resistant prostate cancer previously treated with docetaxel. / Wissing, M.D.; Coenen, J.L.L.M.; van den Berg, P.; Westgeest, H.M.; van den Eertwegh, A.J.M.; van Oort, I.M.; Bos, M.M.; Bergman, A.M.; Hamberg, P.; ten Tije, A.J.; Los, M.; Lolkema, M.P.J.K.; de Wit, R.; Gelderblom, H.

In: International Journal of Cancer, Vol. 136, No. 6, 2015, p. E760-E772.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - CAST: A retrospective analysis of cabazitaxel and abiraterone acetate sequential treatment in patients with metastatic castrate-resistant prostate cancer previously treated with docetaxel

AU - Wissing, M.D.

AU - Coenen, J.L.L.M.

AU - van den Berg, P.

AU - Westgeest, H.M.

AU - van den Eertwegh, A.J.M.

AU - van Oort, I.M.

AU - Bos, M.M.

AU - Bergman, A.M.

AU - Hamberg, P.

AU - ten Tije, A.J.

AU - Los, M.

AU - Lolkema, M.P.J.K.

AU - de Wit, R.

AU - Gelderblom, H.

PY - 2015

Y1 - 2015

U2 - 10.1002/ijc.29231

DO - 10.1002/ijc.29231

M3 - Article

C2 - 25242736

VL - 136

SP - E760-E772

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 6

ER -

Wissing MD, Coenen JLLM, van den Berg P, Westgeest HM, van den Eertwegh AJM, van Oort IM et al. CAST: A retrospective analysis of cabazitaxel and abiraterone acetate sequential treatment in patients with metastatic castrate-resistant prostate cancer previously treated with docetaxel. International Journal of Cancer. 2015;136(6):E760-E772. https://doi.org/10.1002/ijc.29231